Aims: Metabolic syndrome (MetS) is associated with increased cardiovascular risk. We hypothesize that early vascular changes are already present at the time of diagnosis of MetS. The relationship of different measures of early vascular impairment with body fat distribution and the natural progression of MetS was examined in newly diagnosed subjects non-pharmacologically treated. Methods: 246 consecutively enrolled subjects were categorized according to the presence of MetS and type 2 diabetes (T2D). Intra-renal Doppler flow was used to ascertain resistive (RI) and pulsatility (PI) indices as markers of vascular resistance. Carotid intima-media thick- ness (IMT), cutis-rectis (CR) and rectis-aorta (RA) thicknesses were measured by ultrasono-...
Objective: To assess whether the diagnosis 'metabolic syndrome' (MS) predicts the degree of subclini...
AbstractAim of the workThe aim of the present work was to assess the effect of metabolic syndrome (M...
OBJECTIVE: Subjects with metabolic syndrome (MetS) and individuals with type 2 diabetes are at high ...
Aims: Metabolic syndrome (MetS) is associated with increased cardiovascular risk. We hypothesize tha...
Background: Carotid intima-media thickness (CIMT) is a strong predictor of cardiovascular events and...
Background and aims: Our objective was to study relationships between the new biomarker of vascular ...
Background: Metabolic syndrome (MetS) is associated with increased risk of cardiovascular disease (C...
BACKGROUND: Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a ...
The importance of metabolic syndrome (MetSy) lies in the fact that its components are proven risk fa...
Metabolic syndrome (MetS), an important component of insulin resistance and cardiovascular (CV) risk...
The metabolic syndrome (MetS) increases cardiovascular disease (CVD) risk. How MetS increases CVD ri...
The metabolic syndrome (MetS) is a clustering of cardiovascular disease CVD) risk factors. Pro-spect...
BACKGROUND: To identify the association between red blood cell distribution width (RDW) and carotid...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Objective: To assess whether the diagnosis 'metabolic syndrome' (MS) predicts the degree of subclini...
AbstractAim of the workThe aim of the present work was to assess the effect of metabolic syndrome (M...
OBJECTIVE: Subjects with metabolic syndrome (MetS) and individuals with type 2 diabetes are at high ...
Aims: Metabolic syndrome (MetS) is associated with increased cardiovascular risk. We hypothesize tha...
Background: Carotid intima-media thickness (CIMT) is a strong predictor of cardiovascular events and...
Background and aims: Our objective was to study relationships between the new biomarker of vascular ...
Background: Metabolic syndrome (MetS) is associated with increased risk of cardiovascular disease (C...
BACKGROUND: Intima-media thickness (IMT) is a validated marker of preclinical atherosclerosis and a ...
The importance of metabolic syndrome (MetSy) lies in the fact that its components are proven risk fa...
Metabolic syndrome (MetS), an important component of insulin resistance and cardiovascular (CV) risk...
The metabolic syndrome (MetS) increases cardiovascular disease (CVD) risk. How MetS increases CVD ri...
The metabolic syndrome (MetS) is a clustering of cardiovascular disease CVD) risk factors. Pro-spect...
BACKGROUND: To identify the association between red blood cell distribution width (RDW) and carotid...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Background and aims We aimed to identify clusters of metabolic syndrome (MetS) components, risky for...
Objective: To assess whether the diagnosis 'metabolic syndrome' (MS) predicts the degree of subclini...
AbstractAim of the workThe aim of the present work was to assess the effect of metabolic syndrome (M...
OBJECTIVE: Subjects with metabolic syndrome (MetS) and individuals with type 2 diabetes are at high ...